FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy* (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent…
Live Christmas trees affect indoor air chemistry, NIST researchers find
Every holiday season, Americans buy nearly 30 million live Christmas trees. Many families enjoy not only having a live tree inside their homes but also smelling the fresh fragrance it…